Alliance for Multi-Specialty Research

Kansas City, MO

Sorting 1 by

Accepting patients

MagnetisMM-7

Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant (MagnetisMM-7)
  • Bispecific Antibody
  • GPRC5D
  • Phase 3